Schlitt H J, Obed A, Oldhafer K J, Manns M P, Pichlmayr R
Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover.
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:519-21.
This study analyzes the course of 62 patients aged over 60 years (i.e., 7% of all recipients) which were liver transplanted over the last 10 years. The data show that the results of transplantation in patients with malignant tumors (n = 25) are unfavorable (20% 5-year survival), while good results could be obtained in patients with benign indications (n = 37), including mainly posthepatitic cirrhosis, but also three fulminant liver failures (75% 5-year survival). Causes of death were mainly septic complications in the early phase and tumor recurrence in patients with malignant disease.
本研究分析了过去10年中接受肝脏移植的62例60岁以上患者（即所有受者的7%）的病程。数据显示，患有恶性肿瘤的患者（n = 25）移植结果不佳（5年生存率为20%），而具有良性指征的患者（n = 37）可获得良好结果，主要包括肝炎后肝硬化患者，还有3例暴发性肝衰竭患者（5年生存率为75%）。死亡原因主要是早期的败血症并发症以及恶性疾病患者的肿瘤复发。
